MSA Safety vs Oruka Therapeutics

MSA Safety (MSA), health care, and Oruka Therapeutics (ORKA), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

MSA Safety and Oruka Therapeutics are valued at about the same: $6.7B and $6.5B. Over the past year MSA Safety's share price has moved +8.64% and Oruka Therapeutics's +262%.

Key facts

MSA Safety market value
$6.7B
Oruka Therapeutics market value
$6.5B
MSA Safety P/E
22.2
MSA Safety revenue
$1.9BFY to 2025-12-31
Superinvestors holding both
0

Market values as of .

MSA Safety vs Oruka Therapeutics: every measure side by side
Measure MSA Safety Oruka Therapeutics
SectorHealth CareHealth Care
Country United States United States
Fiscal year ends2025-12-312025-12-31
Size
Market cap$6.7Bhigher$6.5Blower
Revenue$1.9B—
Earnings$278.9Mhigher-$105.4Mlower
Employees5,300higher68lower
Total assets$2.6Bhigher$488.6Mlower
Valuation
P/E22.2—
P/S3.6—
P/B4.7lower5.4higher
Dividend yield1.26%higher0.00%lower
Profitability
Operating margin19.8%—
Balance sheet
Net assets$1.4Bhigher$471.9Mlower
Total liabilities$1.2Bhigher$16.7Mlower
Total debt$580.9M—
Cash on hand$165.1Mhigher$46.9Mlower
Price change
Today+1.38%higher-2.94%lower
1 year+8.64%lower+262%higher

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

Loading the one-year price chart…

Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

Both (0)

None of the tracked investors.

Oruka Therapeutics only (3)

Percentages are each holding's share of that investor's reported portfolio. Who owns MSA · Who owns ORKA

Further comparisons

Learn

Questions and answers

Which is bigger, MSA Safety or Oruka Therapeutics?

By market value, MSA Safety is the larger: $6.7B against $6.5B for Oruka Therapeutics.

Which has the higher dividend yield?

MSA Safety: 1.26%, against 0.00% for Oruka Therapeutics. Dividend yield is the last twelve months' dividends as a share of today's share price.

Which superinvestors own both MSA Safety and Oruka Therapeutics?

None of the tracked superinvestors holds both in their latest 13F filing. 4 hold MSA Safety and 3 hold Oruka Therapeutics.

Cite this page

Funkfolio, “MSA Safety vs Oruka Therapeutics”, data as of 18 November 2026. https://funkfolio.com/compare/msa-vs-orka

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.